Magnetic resonance (MR) methods to detect and quantify fluorine (
19 F) nuclei provide the opportunity to study the fate of cellular transplants in vivo. Cells are typically labeled with 19 F nanoparticles, introduced into living organisms and tracked by 19 F MR methods. Background-free imaging and quantification of cell numbers are amongst the strengths of 19 F MR-based cell tracking but challenges pertaining to signal sensitivity and cell detection exist. In this study we aimed to overcome these limitations by manipulating the aminophospholipid composition of 19 F nanoparticles in order to promote their uptake by dendritic cells (DCs). As critical components of biological membranes, phosphatidylethanolamines (PE) were studied. Both microscopy and MR spectroscopy methods revealed a striking (at least one order of magnitude) increase in cytoplasmic uptake of 19 F nanoparticles in DCs following enrichment with 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE). The impact of enriching 19 F nanoparticles with PE on DC migration was also investigated. By manipulating the nanoparticle composition and as a result the cellular uptake we provide here one way of boosting 19 F signal per cell in order to overcome some of the limitations related to 19 F MR signal sensitivity. The boost in signal is ultimately necessary to detect and track cells in vivo.
T racking immune cells in vivo is a prerequisite for understanding the development of pathologies associated with disorders of the immune system 1 . Dendritic cells (DCs) are immune cells that play key roles in the development of immunity and immunopathology. Of note, an understanding of the distribution and fate of cells such as DCs following their therapeutic application in vivo such as in cancers is crucial to assess treatment efficacy 2 . The lack of a priori knowledge of the kinetics and dynamics of these cells during physiological and pathological settings makes their localization a challenging task. It is therefore a top priority to develop methods for the non-invasive spatiotemporal tracking of immune cells in vivo that can be easily transferred to the clinical scenario [3] [4] [5] [6] . Magnetic resonance imaging (MRI) offers an ideal solution for tracking cells in vivo due to its non-invasiveness and clinical translation as well as the opportunity of repetitive measurements and longitudinal studies. Major challenges in differentiating cells from the recipient tissue and signal sensitivity constraints nevertheless exist. For instance, iron oxide nanoparticles that reduce T 2 * relaxation 7 in MR have been used to label cells, however present a challenge whereby the contrast created by the labeled cells is not easily distinguishable from other intrinsic tissue contrasts 8 . This limitation of cellular MRI is surmounted by fluorine ( 19 F) MR techniques 3 . Carbon-bound fluorine is absent in living organisms. This guarantees background-free MR signals for externally-applied 19 F compounds. Therefore 19 F MR techniques are advantageous for localizing 19 F-containing exogenous agents in vivo since they permit complete signal selectivity and specificity [9] [10] [11] . Importantly, the 19 F MR signal can also be equated to measurable cell numbers within defined regions 6, 12 . For in vivo tracking, cells are typically labeled with nanoparticles enriched with perfluorocompounds (PFCs) prior to their introduction into living organisms [3] [4] [5] [6] . These compounds possess unique properties (inertness, biocompatibility and hydrophobicity) which stem from OPEN SUBJECT AREAS:
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the C-F bonds within the molecular structure 13 . Hydrophobicity becomes more significant with increasing number of 19 F atoms and a critical factor for increasing the ability of these compounds to cross biological membranes 14, 15 . Making use of these properties, 19 F-rich nanoparticles are prepared via various techniques -commonly by emulsifying PFCs with phospholipids or surfactants -in order to label and track immune cells in vivo with the aid of combined 19 F and anatomical/proton ( 1 H) MR imaging as well as 19 F spectroscopy techniques [3] [4] [5] [6] . Notwithstanding the benefits specified above, some limitations and challenges exist for 19 F-based MR techniques, especially those pertaining to detection limit and signal sensitivity. These limitations come at a cost in increased signal averaging and thus acquisition times to compensate for low signal-to-noise ratio (SNR). There is a need to optimize cellular 19 F MR methods especially since clinical trials with DC vaccines have thus far provided a proof-of-principle as cancer therapy 16 and the applicability of 19 F MR techniques for DC vaccines are being explored in colorectal cancer patients 17 . In the present study we explored the possibility of altering the composition of 19 F nanoparticles in order to maximize their uptake by DCs and therefore to promote the 19 F signal per cell. To meet this goal, we investigated the incorporation of phosphatidylethanolamines (PEs) into the 19 F nanoparticle shell. PEs are aminophospholipids that constitute an integral part of biological membranes 18, 19 . These aminophospholipids are cone-shaped, they do not form bilayers but inverted hexagonal phases, are believed to exert a lateral pressure that regulates membrane curvature and, are thought to stabilize membrane proteins in their optimum conformations 20 . PE analogs have been used successfully in non-viral transfection systems 21, 22 as well as in nanotube carriers for drug delivery 23 . For all these reasons we studied the influence of PE enrichment on the uptake of 19 F nanoparticle by DCs. Using both electron microscopy and 19 F MR spectroscopy we observed a dramatic increase in uptake of 19 F nanoparticles enriched with 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) by DCs. As a result, the 19 F signal/ cell was increased by at least one order of magnitude and the cell detection limit considerably reduced. With this advantage at hand we could reduce the PFCE concentration per nanoparticle to avoid impairment in cell function, particularly cell migration. Our findings further offset the constraints of 19 F MR and bring us a step closer to the crucial goal of ultimate signal sensitivity and minimal cell detection limit.
Results Dipalmitoyl-Phosphoethanolamine promotes nanoparticle uptake by DCs. Considering the power of PE analogs to promote cellular uptake in transfection and drug delivery systems [21] [22] [23] , we first set off to enrich 19 F-rich (PFCE) nanoparticles (NP) used in our previous studies 5, 6, 12 with different phospholipids of the phosphoethanolamine (PE) family ( Figure 1A ). The basic nanoparticles were prepared using Pluronic F-68 block copolymer. To enrich the 19 F nanoparticles with PE we chose two analogs differing in their two long fatty acid hydrocarbon chains; one PE contained one unsaturated bond (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, POPE) and the other PE consisted of only saturated bonds (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, DPPE). Also consisting solely of saturated bonds was the third candidate we chose: 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), bound to polyethylene glycol-2000 (DSPE-PEG2000). PEG is widely employed as polymeric steric stabilizer and is anchored to stealth liposomal surfaces via cross-linked DSPE lipid 24, 25 . PEG2000 was chosen since blocks of higher molecular weight in similarly-sized nanoparticles have been shown to reduce nanoparticle uptake in macrophages (uptake: PEG2000 . PEG5000 . PEG10000) 26 . We used DPPE and POPE to enrich Pluronic-based PFCE-containing nanoemulsions and prepared liposomal PFCE nanoparticles using DSPE-PEG2000. For all nanoparticle preparations, the molar fraction of the constituents and the physical characteristics (size, polydispersity, surface charge) are shown in Table 1 .
To determine differences in uptake between the different nanoparticle groups we performed , fixed in 2% PFA and transferred (10 6 ) to NMR tubes. After positioning in a 19 F-tuned loop coil (see Methods), 19 F signal was acquired using a 90u block excitation pulse with 10 kHz bandwidth and the PFCE amount per 10 6 calculated using a 500 mM PFCE standard. Intracellular appearance of Dipalmitoyl-Phosphoethanolamineenriched nanoparticles. Despite the dramatic differences in 19 F signal within DCs between the different nanoparticles, we did not observe any conspicuous differences in the shape of the nanoparticles employed as investigated by Cryo-TEM ( Figure 2A ). We next went on to investigate whether the striking increase in 19 F signal in the DPPE-enriched nanoparticles was the result of increased nanoparticle uptake. In ultrathin sections of DCs derived from the same culture conditions, we observed intense differences in cytoplasmic uptake between the nanoparticle formulations ( Figure 2B , EM images in upper two panels and lower left panel). We commonly observed the nanoparticles as white globules within the cell cytoplasm but similar to our previous observations 5 the nanoparticles also often appeared compartmentalized as clusters in a lipid membrane capsule within an amorphous grey compartment. We also observed increased DC uptake of nanoparticles enriched with DPPE linked to the tracer dye Rhodamine as shown from the Rhodamine fluorescence imaged by laser scanning microscopy , fixed in 2% PFA and transferred (10 6 ) to NMR tubes. 19 F signal was acquired using a 90u block excitation pulse and the PFCE amount per 10 6 calculated using a 500 mM PFCE standard. ( Figure 2B , LSM image in lower right panel); these nanoparticles were also loaded into DCs similarly to the non-Rhodamine linked DPPEenriched 19 F nanoparticles. As a next step, the same groups of cells labeled with basic (-), DPPE or DPPE-Rhodamine 19 F nanoparticles as well as DSPE-PEG2000 liposomes were investigated by 19 F MRS ( Figure 2C ). Similarly to the results in Figure 1B , we observed a significant increase in Higher concentrations of 19 F label hinder DC migration. Ultimately, the 19 F-labeled DCs will be applied in living organisms. Therefore it was necessary to determine the influence of increasing PFCE labeling on DC migration for both DPPE-enriched as well as basic 19 F nanoparticles. For this, we employed an agarose assay to determine the chemotaxis of DCs towards a chemokine gradient following maturation with bacterial lipopolysaccharide (LPS). In the initial experiments comparing 19 F signal between basic and DPPE nanoparticles we employed 10-20 mmol of PFCE to label 10 7 cells (Figure 1-2 ). When we investigated the influence of 10 mmol PFCE label on DC migration, we observed differences in the number of DCs moving towards chemokine between unlabeled cells treated for 18 h with LPS and cells labeled with 19 F nanoparticles ( Figure 4A ). For DCs labeled with DPPE 19 F nanoparticles, quantities of PFCE higher than 10 mmol per 10 7 cells reduced the migration of DCs towards chemokine by more than 50% ( Figure 4B ). For lower doses of PFCE -specifically 5 mmol per 10 7 cells -the reduction in migration was less extensive and the difference between DPPE and basic 19 F nanoparticles less substantial; the inhibition in migration for DPPE-NP labeled cells was 35% (n 5 1270) and the inhibition in migration for basic-NP labeled DCs was 22% (n 5 1555) in comparison to unlabeled DCs (n 5 1985) ( Figure 4B ). This finding and considering our previous observation that 5 mmol PFCE in DPPE nanoparticles generate an equivalent 19 F signal by at least one order more PFCE in basic nanoparticles ( Figure 3B ), led us to employ 5 mmol PFCE for all the following experiments.
Lower number of cells detected following labeling with DPPEenriched nanoparticles. Using 5 mmol PFCE for both DPPE and basic 19 F nanoparticles we next measured the intracellular 19 F signal in increasing numbers of DCs to determine the cell detection limit. We measured the F label PFCE. DCs were labeled with nanoparticle preparations using PFCE concentrations between 2 mmol and 40 mmol) per 10 7 , fixed in 2% PFA and transferred (10 6 ) to NMR tubes. 19 F signal was acquired using a 90u block excitation pulse and spectral representation using a FFT of the acquired FID. (b) The 19 F signal was quantified from the intercept of the FID fit and the PFCE amount per 10 6 was calculated using a 500 mM PFCE standard. From the spectral representation of the cell dilution curves it was already evident that far less DPPE-NP labeled DCs could be detected than basic-NP labeled DCs ( Figure 5A ). It should be noted that in these experiments (in line with the chemotaxis assays above) we used low PFCE labeling doses (5 mmol per 10 7 cells) in contrast to previously published work where we commonly employed 20 mmol per 10 7 cells 5, 6, 12 . In the present experiments we observed that a minimum of 10 6 DCs labeled with basic nanoparticles (5 mmol) were required to achieve a detectable Figure 6B ). We used the same radio frequency volume coil used for tracking DCs in mice, in order to be able to project our findings to the in vivo experiment. For the volume used to embed cells in agarose (100 ml) within NMR tubes it was sufficient to place a (5 3 5 3 5) mm 3 PRESS voxel that covered the entire sample ( Figure 6B ). The 100,000 1,000,000 10,000,000 H nuclei were acquired using the bSSFP sequence and post-processing of data using ImageJ (National Institutes of Health, USA, http://imagej.nih.gov/ij). (b) After acquisition of the bSSFP images, a (5 3 5 3 5) mm 3 voxel was placed over the whole region of cells in agarose and spectra were acquired using a PRESS-protocol for 19 (10 7 ) labeled with DPPE-enriched nanoparticles were intradermally injected in the left hind limb and DCs (10 7 ) labeled with basic nanoparticles in the right hind limb of C57BL/6 mice. Three hours following intradermal application a (3 3 3 3 3) mm 3 voxel was placed around left and right popliteal lymph node and the 19 F content measured within each lymph node using PRESS sequence as described above. To study the signal and migration efficiency of DPPE-NP labeled DCs in vivo, we next applied DCs ( 10 7 ) to the left hind limbs of C57BL/6 mice and compared their 19 F signal to those labeled with basic 19 F nanoparticles (right hind limb). Three hours following intradermal application we placed a (3 3 3 3 3) mm 3 PRESS voxel around both left and right popliteal lymph node and measured the 19 F signal within each lymph node using PRESS sequence as described above. Both from the 19 F/ 1 H MR imaging as well as from the voxel-based spectra illustrating the region-specific 19 F signal we observed that DPPE-NP labeled DCs gave a more prominent signal in vivo than the basic-NP labeled DCs ( Figure 6C ). Using the cell calibration curves described above ( Figure 5B ) and the FID values at t 5 0 for the PRESS spectra, we could translate the quantified 19 F signal to the number of cells within the specific lymph node regions: we calculated that after 3 hours 2.85 3 10 6 DPPE-NP labeled DCs were present in the left lymph node and 0.79 3 10 5 basic-NP labeled DCs in the right lymph nodes ( Figure 6C ).
F MRS (see Methods). (c) DCs

Discussion
Phosphatidylethanolamines (PEs) are aminophospholipids that constitute an integral part of biological membranes. However, PE analogs have also been employed as components of non-biological systems such as non-viral transfection agents 21, 22 and as coatings of poorly soluble carbon nanotubes to promote cellular uptake 23 . In the cell, PEs are mainly found in the inner leaflet of the lipid bilayer 27 and make up over one fourth of the whole membrane 28 . PEs play a role in membrane fusion and in cell division 29 . These phospholipids are translocated to intracellular surfaces via ATP-dependent mechanisms to maintain asymmetrical distribution within the membrane leaflet 30, 31 . Aminophospholipid asymmetry is necessary for preserving the viability of the cell 18 . The phospholipids PE, PC (phosphatidylcholine), PS (phosphatidylserine), PI (phosphatidylinositol) and SM (sphingomyelin) are irregularly distributed throughout the cellular membrane (2354351259 of PC5PE5PS5PI/SM) in dendritic cells 32 . The variable distribution of phospholipids is necessary for endocytosis in DCs 33, 34 . In this study we investigated the influence of two PE analogs on the uptake of fluorine-rich nanoparticles into DCs. We made use of 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) to enrich basic nanoparticles with PE. These PEs possess different phase transition temperatures (POPE: 125uC 35 ; DPPE: 164uC 36 ) and their assemblies have very different fluidity. One important difference between the two analogs is the presence of an unsaturated bond within one of the fatty acid hydrocarbon chains in POPE; both fatty acid chains in DPPE are made up of only saturated bonds ( Figure 1A) .
We found that anchoring DPPE to nanoparticle structures dramatically improved their uptake by DCs (Figures 1-3, Figures 5-6 ). We also observed an increase in cellular uptake when incorporating POPE into the nanoparticle structure; however the increased uptake was not as remarkable when compared to DPPE ( Figure 1B) . DSPE-PEG2000 was without any effect (Figures 1-2) . In our study we chose PEG2000, with an intermediate molecular weight, in order to stabilize DSPE-based nanoparticles and secure their uptake by DCs. Larger PEG chains are associated with reduced phagocytosis: PEG2000 nanoparticles are taken up more efficiently by macrophages than PEG4000, PEG5000 and PEG10000 coated nanoparticles 26, 37 .
Earlier studies reported that covering nanoparticles with higher MW PEG (e.g. PEG5000) prolongs their circulation time in vivo [38] [39] [40] , probably due to the decreased phagocytosis and thereby protection from the reticuloendothelial system 26, 37 . In addition to cell uptake and circulation time, the length of the PEG block influences other biological aspects such as target recognition and uptake of delivery systems mediated by address molecules. While long PEG chains may cover the vectors, short PEG chains do not inhibit their enzymatic degradation 41 . Phospholipid-based drug delivery systems modified with PEG2000 are highly efficient and specific at drug targeting in tumor tissue, and remain longer in tumor tissue compared to other DSPE-based carriers with other PEG masses [42] [43] [44] . Molecular targeting and cellular uptake can be further enhanced by modification with vector molecules such as receptor-recognizing and cell-penetrating peptides 45, 46 . In our study we did not modify the DSPE-PEG and do not observe any changes in uptake by DCs. Our finding correlates with transfection studies that showed that increasing number of methyl or methylene groups are progressively less active in transfection 47 . Furthermore, PEG-lipids were found to impair transfection efficacy 22 . In future it will be interesting to study the impact of peptide-modified DSPE-PEG nanoparticles to promote cellular uptake in DCs 46, 48 . The observation that DPPE is superior to POPE with regard to cellular uptake is however surprising since liposomal transfection formulations doped with PE analogs revealed that analogs with increasing acyl chain saturation were progressively less active than unsaturated analogs 47 . In our study we enriched nanoparticles generated from emulsification of PFCE with Pluronic with DPPE. Since PE is strictly bound to the cytosolic leaflet, the observed increased efficiency of internalization of DPPE-enriched nanoparticles by DCs could be explained by an active process translocating PE to the inner membrane surface. It has been shown that multiple unsaturation of the fatty acyl chain significantly decreases the interaction with cholesterol in both bilayers and monolayers 19 . The success of conveying nanocomplexes into the intracellular compartment is dependent on several factors: hydrophobic alkyl side chains, saturation of C-C bonds in hydrophobic moieties, the head group of the phospholipids utilized to make up the nanocarrier. In a study comparing the combination of a number of phospholipids to liposomal nanoparticles used for gene delivery, combinations containing DPPE and DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) were most effective with regards to cellular transfection 49 . PE and PS aminophospholipids are present in cell-derived membrane vesicles: microparticles, microvesicles, exosomes 50 . Recently a study reported that PE is extensively found on the external surface of microparticles derived from various human cellular sources 51 . Although cell-derived membrane vesicles were first discovered as a product of platelets during blood coagulation 52 and thought to be cellular waste, it is now becoming clear that they play a crucial role in intercellular communication 53, 54 that may include fusion with their target cells 55 . Therefore it is conceivable that DPPE-enriched nanoparticles would behave in a similar fashion as these cellular vesicles in order to translocate into intracellular compartments of DCs.
Two clear differences between POPE and DPPE that could explain the differences in cellular uptake are: (i) the presence of an unsaturated bond in POPE and (ii) their dissimilar phase transition temperatures from fluid to liquid crystalline of 125uC for POPE 35 and 164uC for DPPE 36 . These distinct differences between 2 otherwise very similar PEs might determine differences in the fluidity of their assemblies and rigidity of their bilayers, thereby conveying differences in the stability of the particulate structures. The character of the acyl chains in aminophospholipids such as PEs has indeed been shown to be crucial for the fluidity of a monolayer; saturated chains lead to lesser membrane fluidity than unsaturated ones 56 . It was recently proposed that aminophospholipids with unsaturated oleoyl chains such as POPE are more prominent in areas of protrusion due to their overall conical shape and aminophospholipids consisting of solely saturated palmitoyl chains (that are considered less conical/ more cylindrical in shape) do not participate in curvature formation 57 . Curvature stress is indeed antagonized by addition of more cylindrical lipids 58 . Changes in the fluidity of biological membranes is also attributed to changes in membrane-initiated signaling processes; for instance, alcohol potentiation of calcium-activated potassium channels is favored by cylindrical phospholipids and blunted by conical ones, regardless of phospholipid head group charge 59 . Differences in membrane fluidity for DPPE and POPE nanoparticles might influence their interaction with DCs and perhaps the mechanism of entry into the cells. In future, it will be interesting to study the mode of internalization for different rigid and fluidic nanostructures by performing inhibition studies of specific uptake routes (e.g. energy-dependent processes, clathrin-mediated endocytosis, caveolae-mediated endocytosis, macropinocytosis) 60 and to follow nanoparticle uptake over time using time-lapse video microscopy 61 . State-of-the-art technologies such as computational modeling 62 or four-dimensional electron microscopy 63 will shed light in the future on structure-property relationships of nanocomposites and singlenanoparticle structural dynamics.
In the present study we showed that the incorporation of DPPE in F MR spectroscopy as well as electron and laser scanning microscopy. The microscopy studies demonstrated that nanoparticles are located inside discrete cytosolic endosomes after internalization by DCs, excluding the possibility of cell surface attachment. The agarose spot chemotaxis assay showed that DCs were less capable at moving towards a chemokine concentration when increasing 19 F label concentration. Although the migration capability of DCs labeled with DPPEenriched fluorine nanoparticles is diminished when compared to non-enriched nanoparticles, when given at the same PFCE labeling concentration, lower concentrations of DPPE-enriched fluorine nanoparticles still resulted in a higher 19 F signal per million cells and minimal decrease in migration, implying a possible threshold for aminophospholipid enriched nanoparticle labelling concentration that increases the 19 F MRS signal without influencing DC migration ability. The order of magnitude increase in 19 F signal we observed with 19 F spectroscopy could be translated into two advantages: (i) we could decrease the concentration of the 19 F label (PFCE) from 20 mmol (employed in our original studies 5, 6, 12 ) to 5 mmol per 10 7 DCs and thus decrease the impact of the 19 F label on cell migration and (ii) the sensitivity gain considerably improved the cell detection limit to enable imaging and quantification of DCs within specific anatomical regions in vivo.
In conclusion, we present evidence that an enrichment of 19 F nanoparticles with DPPE aminophospholipids enhances their uptake by DCs, thereby promoting cellular detection by various 19 F MRI and MRS methods. By promoting cellular uptake of 19 F label in cellular transplants -such as in DC vaccines for cancer therapywe contribute to some of the solutions required to overcome the limitations and challenges of cellular MR imaging, particularly with respect to the barriers pertaining to detection limit and signal sensitivity.
Methods
Nanoparticle preparation. Nanoparticles with high fluorine content were prepared by emulsifying Perfluoro-15-crown-5-ether (PFCE, Fluorochem, Derbyshire, UK) via direct sonication, using a ultrasonic homogenizer (Hielscher Ultrasonic GmbH, Teltow, Berlin, Germany). PFCE was emulsified in Pluronic F-68 (Sigma-Aldrich, Germany) for 10 minutes on ice (1.2 M end concentration) to generate a basic formulation: Basic 19 F nanoparticles (NP). To enrich the basic particles with DPPE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, Figure 1A , Avanti Polar Lipid, Inc., Alabaster, AL) diluted Pluronic-basic nanoparticles were mixed with DPPE and further emulsified using the same conditions to obtain a final PFCE concentration of 400 mM and varying DPPE concentrations of 2.5-25 mM (DPPE 19 F NP). The same procedure was used to prepare the Pluronic-Rhodamine-DPPE (DPPE-Rhodamine 19 F NP) and nanoparticles enriched with POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, Figure 1A , Avanti Polar Lipid, Inc., Alabaster, AL). DSPE-PEG2000-PFCE nanoparticles were prepared by first coating a vial with 10 mg of DSPE-PEG2000 (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N[methoxy(polyethylene glycol) -2000]), Avanti Polar Lipid, Inc., Alabaster, AL) and then sonicating PFCE in the vial for 10 minutes on ice, to achieve a final concentration of 120 mM PFCE and 3.75 mM DSPE-PEG2000.
Zeta potential and other physical characteristics of nanoparticles. To study the physical characteristics of the above nanoparticles, dynamic light scattering (DLS) data was obtained using a Zetasizer Nano ZS instrument (Malvern Instruments, Worcestershire, UK), backscatter detection at 173 degrees and 635 nm laser module at 25uC. DLS provides information on a number of parameters including intensityweighted z-average diameter, peak diameter and width, zeta (f) potential and polydispersity index (PdI). All these physical characteristics of the different nanoparticles were documented and are shown in Table 1 . The z-average diameter was used for particle size since it gives an intensity-weighted harmonic diameter and is ideal for comparing different analyses. The PdI is extrapolated from the DLS function and quantitatively describes the particle size distribution best. PdI ranges from 0.01 for monodispersed particles to 0.7 for particles that have a very broad size distribution. The generated nanoparticles have a PdI , 0.3, indicating a relatively low polydispersity and narrow size distribution. The f potential was also indirectly determined by measuring the electrophoretic mobility of the nanoparticles under a constant voltage of 40 mV at 25uC.
Cryotransmission Electron Microscopy (Cryo-TEM) of Nanoparticles. Nanoparticle preparations were plunge-frozen onto glow discharged holey carbon grids (Quantifoil Micro Tools, Jena, Germany) in liquid ethane using the environment-controlled Vitrobot (Vitrobot MarkIV, FEI, Eindhoven, The Netherlands). Briefly, 3 ml of the nanoparticle solution were applied onto the grid which was held by tweezers inside the climate chamber (22uC, 100% relative humidity) of the Vitrobot. The solution was automatically blotted with filter paper leaving a thin film of the nanoparticle solution over the holes. The film was allowed to relax for 10 s prior to plunge freezing the sample on the grid in liquid ethane cooled near to its freezing point. Vitrified nanoparticle samples were imaged at 2170uC using a Gatan cryo-transfer holder (Gatan 626, Gatan Inc. Pleasanton, USA) and standard low-dose imaging conditions (1 e 2 /Å 2 .s) 64 at a Tecnai G2 F20 transmission electron microscope (FEI, Oregon, USA), operated at 200 kV. Images were acquired at 3 25,000 magnification on a 2k 3 2k CCD camera (894 Ultrascan 1000, Gatan Inc., Pleasanton, USA).
DC Preparation. DCs were prepared from bone marrow (BM) suspensions as previously described 65 . Briefly, BM from femurs of C57BL/6 mice were grown in RPMI-1640 medium containing 10% FCS (Biochrom, Germany) and supplemented with 30 ng/ml GM-CSF. After 9 days in culture, DCs were incubated overnight in the presence of different 19 F nanoparticle preparations (end PFCE concentration ranging from 0.1-2 mM or 2-40 mmol/10 6 cells depending on the experiment) and 1 mg/ml full-length chicken EndoGrade ovalbumin (endotoxin conc.,1 EU/mg; Hyglos, Regensburg, Germany) and 0.5 mg/ml lipopolysaccharide (LPS). Following incubation, unbound 19 F nanoparticles were washed thoroughly from the culture dishes by washing with warm PBS. DCs were then harvested and prepared for the ensuing experiments.
Transmission Electron Microscopy (TEM) of DCs. DCs were fixed for 24 hours in PBS containing 2% glutaraldehyde and postfixed for 2 h with 1% osmium tetroxide. Cell pellets were then dehydrated in an ascending series of ethanol and embedded in Poly/Bed 812 (Polysciences, Eppelheim, Germany). Ultrathin sections were stained with uranyl acetate and lead citrate. Sections were imaged using a FEI Morgagni electron microscope (FEI, Eindhoven, The Netherlands) and iTEM software 5 .
Laser Scanning Microscopy (LSM) of DCs. Intracellular fluorescence in DCs labeled with fluorescently-labeled nanoparticles was investigated using an LSM780 laser scanning microscope (Carl Zeiss MicroImaging GmbH, Jena, Germany). DCs were harvested on day 9, washed and seeded onto 4-chamber m-slide plates (Ibidi GmbH, München, Germany) and after 4 h labeled with 19 F nanoparticles. Prior to LSM, unbound nanoparticles were washed thoroughly from the m-slide plates by washing with warm culture medium.
Chemotaxis of DCs. DC motility towards chemokine following labeling with 19 F nanoparticles was determined using an agarose spot assay, as previously described 66 . Briefly, a 0.5% agarose solution was prepared, cooled to 40uC and mixed with chemokine (2000 ng/ml CCL21) or PBS (as -ve control); thereafter the agarose solution was pipetted as 10 ml spots onto 35-mm glass dishes (MatTek Corporation, Ashland, MA, USA). Following harvesting, DCs labeled with 19 F nanoparticles were introduced, together with culture medium, to the glass dishes and incubated for 4 h at 37uC (5% CO 2 ). The number of cells entering the agarose spot was determined by acquiring and fusing the microscope images for all the fields of views (FOV) making up the 10 ml agarose spot and counting all cells entering the corresponding spot. Image processing (including FOV fusion) and analysis (mainly cell counting) were done with Fiji (Image JA v1.47p, Open source software, NIH, Bethesda, Maryland, USA) 67 . For fusing all images the Stitching plugin was used and for counting the 3 voxel within the region of interest covering the whole cells in agarose ( Figure 6 ). Then we employed the FastMap 68 method for volume specific magnetic field (B 0 ) shimming. After B 0 shimming, the spectra were acquired using a PRESS-protocol for 19 F MRS: TR 5 1500 ms, TE 5 11.6 ms, voxel size (5 3 5 3 5) mm 3 , number of repetitions 5 512, scan time 5 13 min. F dual-tunable volume birdcage resonator (Rapid Biomed, Würzburg, Germany) with 35 mm inner diameter and 50 mm length. The bSSFP sequence was chosen because it was also used for the in vivo experiments (described below); it has been shown previously to provide very high SNR, allowing for high spatiotemporal resolution image acquisitions in reasonable scan times, and because it produces very good soft tissue contrast, related to their T 2 /T 1 relaxation times 69 . The scan parameters for bSSFP were as follows for proton ( To reduce banding artefacts across the SSFP images for both nuclei, 4 acquisitions were made using a 0u, 90u, 180u and 270u phase cycling scheme. The four acquisitions were combined by the sum of squares method using ImageJ (National Institutes of Health, USA, http://imagej.nih.gov/ij). ) into the hind limb of C57BL/6 mice and imaged between 4-18 h following injection. Shortly before and during the MR session, mice were anesthetized using a mixture of isoflurane as inhalation narcosis (0.5-1.5%), pressurized air and oxygen. Mice were imaged on the 9.4 T animal MRI using the same 1 H/ 19 F dual-tunable volume birdcage resonator as above (Rapid Biomed, Würzburg, Germany) and the same 3D bSSFP pulse sequences. The temperature of the mice was regulated at 37uC. The respiration rate and temperature was monitored by a remote monitoring system (Model 1025, SA Instruments Inc., NY, USA). For quantification of the 19 F content within the lymph node regions, we employed the PRESS sequence as above after placing a (3 3 3 3 3) mm 3 voxel around the lymph nodes. After FastMap for volume selective B 0 shimming, 19 F spectra within the lymph nodes were acquired using the same PRESSprotocol for 19 F MRS as above.
In vitro
In vivo
MR Data Collection and Analysis. For both in vivo and in vitro MR-measurements a Redhat RHEL4 system and Paravision v5 (Bruker Biospin, Ettlingen, Germany) software were used. NMR data processing, analysis and spectral presentation were performed in the Matlab environment (Matlab version 7.10.0.499, R2010a, The MathWorks, Inc., Natick, Massachusetts, USA). Differences between groups were analyzed by the student t-test. A p-value of p , 0.05 was considered to be statistically significant.
